Pulmatrix Inc (PULM)
1.96
-0.07
(-3.44%)
USD |
NASDAQ |
May 03, 16:00
1.96
0.00 (0.00%)
After-Hours: 20:00
Pulmatrix Profit Margin (Quarterly): -94.60% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -94.60% |
September 30, 2023 | -215.3% |
June 30, 2023 | -206.9% |
March 31, 2023 | -296.7% |
December 31, 2022 | -246.8% |
September 30, 2022 | -269.9% |
June 30, 2022 | -345.2% |
March 31, 2022 | -428.7% |
December 31, 2021 | -884.0% |
September 30, 2021 | -765.6% |
June 30, 2021 | -170.9% |
March 31, 2021 | -295.3% |
December 31, 2020 | -145.0% |
September 30, 2020 | -241.4% |
June 30, 2020 | -33.43% |
March 31, 2020 | -169.7% |
December 31, 2019 | -239.8% |
September 30, 2019 | -252.8% |
Date | Value |
---|---|
June 30, 2019 | -162.8% |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | -3.41K% |
December 31, 2017 | |
September 30, 2017 | -1.33K% |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | -8.40K% |
September 30, 2016 | -5.18K% |
June 30, 2016 | -3.53K% |
March 31, 2016 | -1.43K% |
December 31, 2015 | -1.65K% |
September 30, 2015 | -757.6% |
June 30, 2015 | -8.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-884.0%
Minimum
Dec 2021
-33.43%
Maximum
Jun 2020
-287.6%
Average
-241.4%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -59.11% |
Return on Assets | -39.41% |
Return on Invested Capital | -59.11% |
Operating Margin (Quarterly) | -101.0% |
Return on Net Operating Assets | -212.0% |